Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Intralymphatic Immunotherapy in Increasing Doses, Substudy [Phase 2, Phase 3]
Phase 2/3 trial update on intralymphatic immunotherapy with increasing doses for seasonal allergic rhinitis; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants [Phase 3]
Phase 3 trial evaluating fexofenadine for seasonal allergic rhinitis in the presence of pollutants has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: MP-AzeFlu Allergen Chamber - Onset of Action Study [Phase 4]
Phase 4 trial update for MP-AzeFlu allergen chamber focusing on onset of action in seasonal allergic rhinitis; the study is completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) [Phase 4]
Phase 4 trial comparing Clarinex tablets to Zyrtec tablets in patients with seasonal and perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442) [Phase 4]
Phase 4 trial update on nasal symptom relief and side effects in hayfever patients treated with desloratadine (Aerius).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) [Phase 4]
Phase 4 trial update comparing Clarinex tablets to Zyrtec tablets in patients with seasonal and perennial allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178) [Phase 4]
Phase 4 trial comparing Clarinex tablets to Allegra tablets in adults with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) [Phase 4]
Phase 4 trial comparing preference for Clarinex tablets versus Zyrtec tablets in patients with seasonal and perennial allergic rhinitis has …
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) [Phase 4]
A Phase 4 trial comparing Clarinex tablets with Allegra tablets in seasonal allergic rhinitis has been completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472) [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of desloratadine syrup in children with seasonal allergic rhinitis with or without ast…
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED) [Phase 2]
Phase 2 trial update on desloratadine with oxybutynin for seasonal allergic rhinitis and post-nasal drip has completed.
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast (generic, Sandoz Inc), updating the product's approval status under the ANDA. Montel…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc., enabling changes to its labeling or indica…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., updating the labeling under an existing ap…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]
Phase 2/3 exploratory trial update for PQ Grass 27600 SU in seasonal allergic rhinitis completed.
-
FDA approval · 2021-11-01FDA Approved: ASTEPRO ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for AStepro Allergy (azelastine HCl) from Bayer HealthCare LLC, resulting in updated labeling for th…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial update comparing mometasone nasal spray to Nasonex nasal spray for relief of seasonal allergic rhinitis completed.
-
FDA approval · 2021-10-15FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under an approved ANDA. This action …
-
FDA approval · 2021-06-17FDA Approved: ASTEPRO ALLERGY — Original Application (Bayer HealthCare LLC.)
FDA approved ASTEPRO ALLERGY (azelastine hydrochloride) under Bayer HealthCare LLC.'s original NDA, establishing its intranasal antihistamin…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: The Effects of Immunotherapy in the Nose [NA]
Completed clinical trial investigating the effects of immunotherapy in seasonal allergic rhinitis with results posted.
-
FDA approval · 2021-04-16FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial comparing safety and efficacy of two steroid treatments for seasonal allergic rhinitis has completed with results posted.
-
FDA label_change · 2021-02-22FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC, resulting in changes to the product lab…
-
FDA approval · 2021-02-18FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals' azelastine hydrochloride and fluticasone propionate nasal spray as an original ANDA, provid…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial comparing two mometasone nasal sprays for seasonal allergic rhinitis; results completed with posted results.